Indiabulls Pharmaceuticals Limited, a active public limited company, was established on 06 July 2016 in Industrial Complex Dundahera, Haryana, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U33119HR2016PLC078088. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹6.50 Cr and a paid-up capital of ₹6.28 Cr.
It upholds a compliant status. Employing 340 professional, Its leadership includes Vidya Nand (Director), Monika Panghal (Director), Anand Kumar (Director). Past directors included Karan Singh Khera, Vidya Nand, Rajender Singh Malhan. It holds no open charges and ₹160.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2Nd Floor, 591,, Udyog Vihar, Phase-V, Industrial Complex Dundahera, Haryana, 122016.
U33119HR2016PLC078088
078088
06 July 2016
₹6.50 Cr
₹6.28 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Indiabulls Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vidya Nand | Director | 20 Aug 2020 | Current |
| Monika Panghal | Director | 22 Aug 2022 | Current |
| Anand Kumar | Director | 20 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Mar 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2020 | Past |
| Pramod Abcsdd | Director | 30 Oct 2018 | Past |
| Pramod Abcsdd | Ceo | 06 Jan 2023 | Past |
| Pramod Abcsdd | Director | 30 Aug 2017 | Past |
| Pramod Abcsdd | Managing Director | 31 Aug 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indiabulls Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.16% increase. The company also saw a substantial improvement in profitability, with a 14.99% increase in profit. The company's net worth observed a substantial decline by a decrease of 36.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Indiabulls Pharmaceuticals had a promoter holding of 84.06% and a public holding of 15.94%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,600,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Oct 2017 | Others | ₹30.00 Cr | Satisfied |
| 05 Sep 2017 | Others | ₹25.00 Cr | Satisfied |
| 29 Aug 2017 | Others | ₹10.00 Cr | Satisfied |
| 01 Jun 2017 | Others | ₹50.00 Cr | Satisfied |
| 31 Mar 2017 | Others | ₹35.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Indiabulls Pharmaceuticals has a workforce of 340 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Indiabulls Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indiabulls Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Indiabulls Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Indiabulls Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on Monika Panghal was appointed as a Director was appointed as a Director on 22 Aug 2022 & has been associated with this company since 3 years 3 months . was documented.
The activity A charge registered on 31 Mar 2017 via Charge ID 100120114 with Others was fully satisfied on 27 Jun 2022. was completed.
Progress on Vidya Nand was appointed as a Director was appointed as a Director on 20 Aug 2020 & has been associated with this company since 5 years 3 months . was documented.
Progress on Anand Kumar was appointed as a Director was appointed as a Director on 20 Aug 2020 & has been associated with this company since 5 years 3 months . was documented.
Indiabulls Housing Finance is leaving risky developer loans and focusing on retail loans. They want to grow their loan book and profits by 20% in the next few years. They also want to change the negative perception around them..
Indiabulls Housing Fin tanked 5%, Indiabulls Real Estate fell 1.3%, Lakshmi Vilas Bank declined 5%, Indiabulls Ventures fell 1%.Earlier on 10 June a plea was filed in the SC, seeking legal action against Indiabulls Housing Fin, Sameer Gehlaut and the directors for alleged misappropriation of money.
The CIN of Indiabulls Pharmaceuticals Limited is U33119HR2016PLC078088.
Indiabulls Pharmaceuticals Limited is headquartered at 2Nd Floor, 591,, Udyog Vihar, Phase-V, Industrial Complex Dundahera, Haryana, 122016.
Indiabulls Pharmaceuticals Limited was incorporated on 06 July 2016.
The current directors of Indiabulls Pharmaceuticals Limited are
The primary industry of Indiabulls Pharmaceuticals Limited is Hospital And Medical Care.
Indiabulls Pharmaceuticals Limited is unlisted.
The authorized capital of Indiabulls Pharmaceuticals Limited is ₹6.50 Cr, and the paid-up capital is ₹6.28 Cr.
The compliance status of Indiabulls Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX